Full Text
PMS23 INITIAL COMBINATION THERAPY WITH INFLIXIMAB VERSUS SEQUENTIAL DMARD MONOTHERAPY- A COST-EFFECTIVENESS MODEL BASED ON THE BEST STUDY

Abstract

Authors

ML Ganz M Prasad YC Yeh JD Miller MW Russell

Back to Volume 11, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×